PDS Biotechnology
PDSB
PDSB
52 hedge funds and large institutions have $137M invested in PDS Biotechnology in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
25% less capital invested
Capital invested by funds: $182M → $137M (-$45.4M)
Holders
52
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.68M | |
| 2 | +$2.84M | |
| 3 | +$1.23M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$998K |
| 5 |
Millennium Management
New York
|
+$694K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$437K | |
| 3 | -$361K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$328K |
| 5 |
Morgan Stanley
New York
|
-$240K |